Society guideline links: Ovarian and fallopian tube disease

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Ovarian, fallopian tube, and peritoneal cancer" and "Society guideline links: Screening for ovarian cancer".)

International

●First international consensus report on adnexal masses – Management recommendations (2017)

Canada

●Society of Obstetricians and Gynaecologists of Canada (SOGC): Clinical practice guideline for the initial investigation and management of adnexal masses (2020)

●SOGC: Clinical practice guideline for the initial investigation and management of benign ovarian masses (2020)

●SOGC: Clinical practice guideline for the diagnosis and management of adnexal torsion in children, adolescents, and adults (2017)

●Cancer Care Ontario (CCO): Management of a suspicious adnexal mass (2016)

United States

●American College of Radiology (ACR): A consensus guideline on O-RADS US risk stratification and management system (2020)

●American College of Obstetricians and Gynecologists (ACOG): Committee opinion on adnexal torsion in adolescents (2019)

●ACOG: Committee opinion on the role of the obstetrician-gynecologist in the early detection of epithelial ovarian cancer in women at average risk (2017, reaffirmed 2019)

●Society of Radiologists in Ultrasound (SRU): Simple adnexal cysts – Follow-up and reporting, update (2019)

●ACR: ACR Appropriateness Criteria on clinically suspected adnexal mass, no acute symptoms (revised 2018)

●ACOG: Practice bulletin for the evaluation and management of adnexal masses (2016)

●National Academy of Clinical Biochemistry (NACB): Laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers (2008)

Europe

●European Society of Urogenital Radiology (ESUR): Recommendations for MR imaging of the sonographically indeterminate adnexal mass, update (2017)

●European Group on Tumor Markers (EGTM): Updated guidelines for the clinical use of cancer biomarkers in epithelial ovarian cancer (2016)

United Kingdom

●British Society for Gynaecological Endoscopy (BSGE): Evidence-based guideline on laparoscopy in pregnancy (2019)

●National Institute for Health and Care Excellence (NICE): Diagnostics guidance on tests in secondary care to identify people at high risk of ovarian cancer (2017)

●Choosing Wisely UK: Royal College of Obstetricians and Gynaecologists − A simple ovarian cyst less than 5cm in diameter in a woman who has not gone through the menopause does not need to be followed up; nor is there any need for a blood test to check levels of the protein CA-125 (2016)

●Royal College of Obstetricians and Gynaecologists (RCOG): Green-top guideline for the management of ovarian cysts in postmenopausal women, 2nd edition (2016)

●RCOG/BSGE: Green-top guideline for the management of suspected ovarian masses in premenopausal women (2011)

Australia–New Zealand

●Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG): Managing the adnexae at the time of hysterectomy for benign gynaecological disease (2017)

●Australian Government: Assessment of symptoms that may be ovarian cancer − A guide for general practitioners (2015)